117 related articles for article (PubMed ID: 25154322)
1. The survival of patients with high grade glioma from different ethnic groups in South East England.
Ratneswaren T; Jack RM; Tataru D; Davies EA
J Neurooncol; 2014 Dec; 120(3):531-6. PubMed ID: 25154322
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.
Jack RH; Davies EA; Møller H
BJU Int; 2010 May; 105(9):1226-30. PubMed ID: 19878505
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer incidence and survival in different ethnic groups in South East England.
Jack RH; Davies EA; Møller H
Br J Cancer; 2011 Sep; 105(7):1049-53. PubMed ID: 21863024
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England.
Jack RH; Davies EA; Møller H
Br J Cancer; 2009 Feb; 100(3):545-50. PubMed ID: 19127253
[TBL] [Abstract][Full Text] [Related]
5. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
[TBL] [Abstract][Full Text] [Related]
6. Does place of death from cancer vary between ethnic groups in South East England?
Coupland VH; Madden P; Jack RH; Møller H; Davies EA
Palliat Med; 2011 Jun; 25(4):314-22. PubMed ID: 21248180
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis for adult glioma in England and Wales.
Tseng MY; Tseng JH
J Formos Med Assoc; 2005 May; 104(5):341-8. PubMed ID: 15959601
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of socioeconomic and geographic variations on survival for adults and children with glioma.
Tseng MY; Tseng JH; Merchant E
J Neurosurg; 2006 Oct; 105(4 Suppl):297-305. PubMed ID: 17328280
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.
Carstam L; Rydén I; Gulati S; Rydenhag B; Henriksson R; Salvesen Ø; Smits A; Jakola AS
J Neurooncol; 2020 Jan; 146(2):329-337. PubMed ID: 31883050
[TBL] [Abstract][Full Text] [Related]
10. Primary liver cancer incidence and survival in ethnic groups in England, 2001-2007.
Jack RH; Konfortion J; Coupland VH; Kocher HM; Berry DP; Allum W; Linklater KM; Møller H
Cancer Epidemiol; 2013 Feb; 37(1):34-8. PubMed ID: 23182222
[TBL] [Abstract][Full Text] [Related]
11. Incidence and management of high grade glioma in Māori and non-Māori patients.
Alexander H; Irwin C; Purdie G; Hunn M
J Clin Neurosci; 2010 Sep; 17(9):1144-7. PubMed ID: 20576437
[TBL] [Abstract][Full Text] [Related]
12. Testis and prostate cancer incidence in ethnic groups in South East England.
Jack RH; Davies EA; Møller H
Int J Androl; 2007 Aug; 30(4):215-20; discussion 220-1. PubMed ID: 17573844
[TBL] [Abstract][Full Text] [Related]
13. The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas: a population-based register study.
Bergqvist J; Iderberg H; Mesterton J; Henriksson R
J Neurooncol; 2018 Sep; 139(3):599-608. PubMed ID: 29846896
[TBL] [Abstract][Full Text] [Related]
14. Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma.
DeLorenze GN; McCoy L; Tsai AL; Quesenberry CP; Rice T; Il'yasova D; Wrensch M
BMC Cancer; 2010 May; 10():215. PubMed ID: 20482871
[TBL] [Abstract][Full Text] [Related]
15. Childhood cancer incidence by ethnic group in England, 2001-2007: a descriptive epidemiological study.
Sayeed S; Barnes I; Ali R
BMC Cancer; 2017 Aug; 17(1):570. PubMed ID: 28841853
[TBL] [Abstract][Full Text] [Related]
16. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
19. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.
Peters KB; West MJ; Hornsby WE; Waner E; Coan AD; McSherry F; Herndon JE; Friedman HS; Desjardins A; Jones LW
J Neurooncol; 2014 Dec; 120(3):499-506. PubMed ID: 25115739
[TBL] [Abstract][Full Text] [Related]
20. Ethnicity and excess mortality in severe mental illness: a cohort study.
Das-Munshi J; Chang CK; Dutta R; Morgan C; Nazroo J; Stewart R; Prince MJ
Lancet Psychiatry; 2017 May; 4(5):389-399. PubMed ID: 28330589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
